Probable Drug Interaction Between Warfarin and Hepatitis C Therapy

HealthDay News – There is a probable interaction between paritaprevir/ritonavir/ombitasvir+dasabuvir (PrOD) [Holkira Pak / Viekira Pak] plus ribavirin with warfarin, according to a case report published online in the Journal of Clinical Pharmacy and Therapeutics. Gina M. Puglisi, PharmD., from VA Maine Healthcare System in Augusta, and colleagues present the case of a probable interaction between PrOD with ribavirin and warfarin in a 58-year-old patient w

Counterfeit Versions of Gilead’s Blockbuster Hepatitis C Drug Found in Israel

Counterfeits of Gilead’s mega-blockbuster hepatitis C treatment Harvoni, which is generating billions per quarter in sales for the company, are emerging in Israel.Switzerland’s drug regulator Swissmedic said over the weekend that the plastic bottles of the counterfeits, which originated in India, were imported via a Swiss trading company and “contain white instead of genuine yellow film-coated tablets,” the regulator said.Swissmedic is working with other E

Information Update – Risk of Serious Liver Injury associated with Hepatitis C Treatments: Holkira Pak and Technivie

OTTAWA, Nov 10, 2015 /CNW/ - In response to new international safety information, Health Canada is advising Canadians that it is working with the manufacturer of Holkira Pak and Technivie to update drug labels (product monographs) to include new information regarding serious liver injury.Holkira Pak and Technivie are both used to treat chronic Hepatitis C viral infection that can lead to serious liver and health problems, including cirrhosis, liver cancer,